Sponsor or institution

Clinical trials and research at Alentis Therapeutics AG

As of November 12, 2026, Find a Trial lists 3 clinical trials run by Alentis Therapeutics AG that are recruiting, at sites in 16 countries (most in France (3), Italy (3), Spain (3)). By phase: Phase 1/2 (2), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest trials

StudyPhaseWhereStatusRegistered
ALE.P03 alone for adults with advanced CLDN1-positive solid tumors Phase 1/2 Phoenix, Arizona and 40 other locations Recruiting Sep 12, 2025
Investigating ALE.P02 for treating specific solid tumors in adults Phase 1/2 Scottsdale, Arizona and 40 other locations Recruiting Dec 24, 2024
ALE.F02 to rescue kidney tissue in rapidly progressive ANCA-associated glomerulonephritis Phase 2 Prague and 52 other locations Recruiting Sep 21, 2023

All recruiting trials (3)

Quick answers

How many clinical trials run by Alentis Therapeutics AG are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 16 countries. The most sites are in France (3 trials), Italy (3 trials), Spain (3 trials), Hong Kong (2 trials), Singapore (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.